Letters

TAG submitted the following letters of support to the NY State assembly Health Committee Members to support Assembly Bills A.3316 (S. 1809) and A.5974 (S. 3900).

Following news of the Trump Administration's abrupt review of HIV treatment and cure research using fetal tissue, TAG and 75 other organizations signed and sent a letter to HHS Secretary Azar on December 21, 2018.

On October 18, 2018, the Trump Administration proposed regulations at the Centers for Medicare and Medicaid Services (CMS) to require publication of the list price of any prescription drug or biological product paid by Medicare or Medicaid in direct-to-consumer (DTC) advertising. While TAG applauds the administration's attention to curbing drastic increases in drug prices, list price transparency in DTC advertisements alone will not be a sufficient measure to bring necessary change.

On October 10, 2018, the Trump Administration proposed sweeping regulations that would put the health and wellbeing of millions of families at risk. TAG is strongly opposed to these proposed changes; read the comment we submitted on December 7.

Read TAG's comment on The Food and Drug Administration (FDA) Notice: Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank; Draft Guidance for Food and Drug Administration Staff, Responsible Parties, and Submitters of Certain Applications and Submissions to the FDA.